IMPROvE-CED trial: intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and nonobstructive …
MT Corban, T Toya, D Albers, F Sebaali… - Circulation …, 2022 - Am Heart Assoc
Background: Coronary endothelial dysfunction (CED) causes angina/ischemia in patients
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients with Angina and Nonobstructive …
MT Corban, T Toya, D Albers… - Circulation …, 2022 - mayoclinic.elsevierpure.com
Background: Coronary endothelial dysfunction (CED) causes angina/ischemia in patients
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive …
MT Corban, T Toya, D Albers, F Sebaali… - Circulation …, 2021 - europepmc.org
Background Coronary endothelial dysfunction (CED) causes angina/ischemia in patients
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive …
MT Corban, T Toya, D Albers, F Sebaali, BR Lewis… - Circulation …, 2022 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Coronary endothelial
dysfunction (CED) causes angina/ischemia in patients with nonobstructive coronary artery …
dysfunction (CED) causes angina/ischemia in patients with nonobstructive coronary artery …
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive …
MT Corban, T Toya, D Albers, F Sebaali… - Circulation …, 2022 - ingentaconnect.com
Background: Coronary endothelial dysfunction (CED) causes angina/ischemia in patients
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive …
MT Corban, T Toya, D Albers, F Sebaali… - Circulation …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Coronary endothelial dysfunction (CED) causes angina/ischemia in patients
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
with nonobstructive coronary artery disease (NOCAD). Patients with CED have decreased …
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive …
MT Corban, T Toya, D Albers, F Sebaali… - Circulation …, 2022 - Am Heart Assoc
BACKGROUND: Coronary endothelial dysfunction (CED) causes angina/ischemia in
patients with nonobstructive coronary artery disease (NOCAD). Patients with CED have …
patients with nonobstructive coronary artery disease (NOCAD). Patients with CED have …